Grateful graduate gives R18 million to UCT for new life-saving meds

Grateful graduate gives R18 million to UCT for new life-saving meds

- Former CEO of Coca-Cola, Neville Isdell, has donated a whopping R18-million to the University of Cape Town (UCT)

- Isdell graduated from the university more than 50 years ago, but remains grateful and the funding will aid the research in African-centric drug discovery

- Professor Kelly Chibale, who was named as 1 of the Fortune magazine’s “50 World’s Greatest Leaders” in 2018, will hold the chair for the centre at H3D

PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!

The University of Cape Town (UCT) has received a huge financial boost thanks to one of its successful alumni.

Former chair and CEO of Coca-Cola, Neville Isdell, has donated a whopping R18 million to the tertiary institution in a tremendous show of gratitude.

Briefly.co.za understands this is the 76-year-old’s second donation in excess of 1-million dollars.

The previous donation went towards the UCT Rugby Football Club as the Neville Isdell Rugby Centre was built.

READ ALSO: Knowledge Musona doubtful that Kaizer Chiefs can afford to buy him out

TimesLIVE reported that the new donation will be used in the field of medical research, with a specific focus on the genetic response of African people.

UCT’s Drug Discovery and Development Centre, H3D, will utilise the funding for the research of new medicines for infectious diseases.

Isdell shared, “I am excited about playing a part in helping to achieve African solutions to public health challenges on the continent and across the world.”

READ ALSO: Throwback Thursday - Remembering the days of Chiefs’ Serge Djiehoua

Thanks to the hefty donation, a Neville Isdell chair in African-centric Drug Discovery and Development Centre will be established.

Professor Kelly Chibale, who was named as one of Fortune magazine’s “50 World’s Greatest Leaders” in 2018, will hold the chair for the centre at H3D.

Chibale is the centre’s founder and director as well and explained that part of the funds would be used towards variable drug response across African populations.

H3D already boasts an exciting potential drug in the fight against malaria.

Chibale expressed his joy as he said, “H3D will need sustainable funding at critical mass if it is to succeed. Should H3D continue to be successful, it could result in the beginning of a home-grown pharmaceutical R&D industry that would focus on the unmet medical needs of African populations and create high-skilled jobs for African scientists.”

PAY ATTENTION: Do you want to know what's trending on Briefly.co.za? Join our WhatsApp group today.

Enjoyed reading our story? Download BRIEFLY’s news app on Google Play now and stay up-to-date with major South African news!

Source: Briefly.co.za

Mailfire view pixel